|
Mechanism5-HT2A receptor agonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Pilz GmbH & Co. KG
0 Patents (Medical) associated with Pilz GmbH & Co. KG
100 Deals associated with Pilz GmbH & Co. KG
100 Translational Medicine associated with Pilz GmbH & Co. KG